Health Headlines: Navigating Global Health Challenges
In recent health news, Chinese scientists stress the need for regional diets to combat obesity, U.S. minority veterans struggle for equal access to key medications, and Cigna dismisses merger talks with Humana. Sigma Healthcare faces shareholder changes post-merger, and WHO addresses mpox emergency status.
In China's battle against rising obesity, scientists propose region-specific diets to bolster health and sustainability. New guidelines aim to standardize obesity treatment as more than half of Chinese adults face weight issues.
Across the United States, racial disparities affect access to Novo Nordisk's medications, Ozempic and Wegovy, vital for diabetes and weight loss. A recent study highlights veterans of minority backgrounds receiving less access than their white counterparts.
Meanwhile, Cigna denies merger plans with Humana, while Australia's Sigma Healthcare witnesses shareholder adjustments post-Chemist Warehouse merger. The WHO schedules a critical meeting to assess the mpox health crisis.
(With inputs from agencies.)
- READ MORE ON:
- health
- obesity
- Chinese diets
- US veterans
- Ozempic
- Wegovy
- Cigna
- Humana
- Sigma Healthcare
- mpox
ALSO READ
Novo Nordisk Shines with Wegovy's Surprising Sales Leap
Novo Nordisk Surges Ahead: Wegovy Sales Exceed Expectations
Wegovy Wins: Novo Nordisk Surges on Strong Weight-loss Drug Sales
Novo Nordisk's Weight-loss Drug Wegovy Shines in Surpassing Sales Forecast
Novo Nordisk's Wegovy Surpasses Sales Expectations, Obesity Drug Market Race Heats Up